US1014986A
(en)
|
1910-01-03 |
1912-01-16 |
Alfred J Ware |
Printing-machine.
|
US1014987A
(en)
|
1910-12-12 |
1912-01-16 |
B L Shrader |
Gang-plow.
|
US3625214A
(en)
|
1970-05-18 |
1971-12-07 |
Alza Corp |
Drug-delivery device
|
US4906474A
(en)
|
1983-03-22 |
1990-03-06 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
US4789734A
(en)
|
1985-08-06 |
1988-12-06 |
La Jolla Cancer Research Foundation |
Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
|
JP2876058B2
(en)
|
1986-08-18 |
1999-03-31 |
エミスフィア・テクノロジーズ・インコーポレイテッド |
Drug delivery system
|
US5143845A
(en)
*
|
1986-09-03 |
1992-09-01 |
Toa Pharmaceutical Co., Ltd. |
Mixture of saccarifying lactic acid producing and butyric acid producing bacteria
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
US5811128A
(en)
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
WO1990001335A1
(en)
|
1988-08-02 |
1990-02-22 |
Borody Thomas J |
Treatment of gastro-intestinal disorders
|
JP2961182B2
(en)
|
1990-03-09 |
1999-10-12 |
ミヤリサン株式会社 |
Pharmaceutical composition for prevention and treatment of Clostridium difficile diarrhea and pseudomembranous colitis
|
JP2961184B2
(en)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
Pharmaceutical composition for prevention and treatment of Clostridium difficile diarrhea and pseudomembranous colitis
|
EP0678034B1
(en)
|
1993-01-11 |
1999-05-26 |
Dana Farber Cancer Institute |
Inducing cytotoxic t lymphocyte responses
|
GB9306473D0
(en)
|
1993-03-29 |
1993-05-19 |
Bioglan Lab Ltd |
Pharmaceutically useful compounds
|
US6241983B1
(en)
|
1994-10-28 |
2001-06-05 |
Metagenics, Inc. |
Bacteria-and fiber-containing composition for human gastrointestinal health
|
US5531989A
(en)
|
1994-10-28 |
1996-07-02 |
Metagenics, Inc. |
Immunoglobulin and fiber-containing composition for human gastrointestinal health
|
JPH08298982A
(en)
*
|
1995-05-02 |
1996-11-19 |
Aasu Giken:Kk |
Complex microbial pharmaceutical preparation
|
WO1998018610A1
(en)
|
1996-10-28 |
1998-05-07 |
Lengerich Bernhard H Van |
Embedding and encapsulation of controlled release particles
|
US7767203B2
(en)
*
|
1998-08-07 |
2010-08-03 |
Ganeden Biotech, Inc. |
Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
|
WO2000015760A1
(en)
|
1998-09-17 |
2000-03-23 |
North American Vaccine, Inc. |
Streptococcal c beta protein compositions
|
ATE290391T1
(en)
|
1998-12-11 |
2005-03-15 |
Urex Biotech Inc |
ORAL ADMINISTRATION OF LACTOBACILLUS FOR THE TREATMENT AND PREVENTION OF UROGENITAL INFECTIONS
|
ID29150A
(en)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
USE OF LACTOBACILLUS SALIVARIUS
|
US7056661B2
(en)
|
1999-05-19 |
2006-06-06 |
Cornell Research Foundation, Inc. |
Method for sequencing nucleic acid molecules
|
ES2321797T3
(en)
|
1999-08-05 |
2009-06-12 |
Societe Des Produits Nestle S.A. |
BIFIDOBACTERIES THAT PREVENT THE DIARRHEA CAUSED BY PATHOGENIC BACTERIA.
|
JP4580542B2
(en)
|
2000-05-17 |
2010-11-17 |
株式會社バイオニア |
Microorganism for treating obesity or diabetes and pharmaceutical composition containing the microorganism
|
US20040062757A1
(en)
|
2001-06-05 |
2004-04-01 |
Finegold Sydney M. |
Method of testing gastrointestinal diseases associated with species of genus clostridium
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
FI110668B
(en)
|
2000-06-20 |
2003-03-14 |
Aboatech Ab Oy |
Use of probiotics for primary prevention of atopic diseases
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
DE10043151A1
(en)
*
|
2000-08-31 |
2002-03-28 |
Peter Steinruecke |
Bone cement with antimicrobial effectiveness
|
EP1227152A1
(en)
|
2001-01-30 |
2002-07-31 |
Société des Produits Nestlé S.A. |
Bacterial strain and genome of bifidobacterium
|
IL157071A0
(en)
|
2001-02-06 |
2004-02-08 |
Nestle Sa |
Endotoxine binding by lactic acid bacteria and bifidobacteria
|
WO2002085415A1
(en)
|
2001-04-17 |
2002-10-31 |
Biomatrix, Inc |
Non-digestible sugar-coated products and process
|
US7101565B2
(en)
|
2002-02-05 |
2006-09-05 |
Corpak Medsystems, Inc. |
Probiotic/prebiotic composition and delivery method
|
US20050069505A1
(en)
|
2002-02-21 |
2005-03-31 |
Lionel Breton |
Orally administrable composition for the photoprotection of the skin
|
ITBO20020564A1
(en)
|
2002-09-06 |
2004-03-07 |
Alfa Wassermann Spa |
BIFIDOBACTERIA AND PREPARATIONS THAT CONTAIN THEM.
|
SE526711C2
(en)
|
2003-01-31 |
2005-10-25 |
Probi Ab |
Novel strains of Bifidobacterium having ability to survive in intestinal tract and produce glutamine and arginine in vivo, useful for preparing medicament for treatment of intensive care patients with intestinal failure
|
CA2559596A1
(en)
|
2003-03-13 |
2004-11-25 |
Universite De Moncton (Bureau De Soutien A L'innovation) |
Antioxidant producing bacterium and uses thereof
|
GB0307026D0
(en)
|
2003-03-27 |
2003-04-30 |
Rowett Res Inst |
Bacterial supplement
|
EP1462116A1
(en)
|
2003-03-29 |
2004-09-29 |
Villitech SARL |
Composition for treating the gastrointestinal tract
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US20050100559A1
(en)
|
2003-11-07 |
2005-05-12 |
The Procter & Gamble Company |
Stabilized compositions comprising a probiotic
|
EP1600060A1
(en)
|
2004-05-25 |
2005-11-30 |
Cognis IP Management GmbH |
Oral and/or topical compositions comprising prebiotics and fatty acid
|
AU2005257033B2
(en)
|
2004-06-23 |
2011-05-12 |
L'oreal |
Method and compositions useful for preventing and/or treating sensitive and/or dry skin
|
CA2471142A1
(en)
|
2004-06-25 |
2005-12-25 |
Pierre Marcotte |
Spring with controlled behaviour
|
US7862808B2
(en)
|
2004-07-01 |
2011-01-04 |
Mead Johnson Nutrition Company |
Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
|
ITMI20041550A1
(en)
|
2004-07-29 |
2004-10-29 |
Proge Farm Srl |
USE OF PROBIOTIC BACTERIA FOR THE PREPARATION OF TOPICAL COMPOSITIONS FOR THE PROTECTION OF THE EPIDERMIS
|
FR2874825B1
(en)
|
2004-09-08 |
2006-12-08 |
Genibio Sarl |
USES OF BENEFICIAL PREBIOTIC OLIGOSACCHARIDES FOR VAGINAL FLORA
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
EP1812068A4
(en)
|
2004-10-29 |
2010-06-09 |
Medimmune Inc |
Methods of preventing and treating rsv infections and related conditions
|
JP5565991B2
(en)
|
2004-12-15 |
2014-08-06 |
株式会社島津製作所 |
Microbe species estimation system and method
|
KR101102914B1
(en)
|
2004-12-28 |
2012-01-10 |
메이지 세이카 파루마 가부시키가이샤 |
Novel strain conferring anti-disease properties to host and bacterial cell composition
|
TW200700074A
(en)
|
2005-03-04 |
2007-01-01 |
Calpis Co Ltd |
Inducer of t cell apoptosis
|
US20060223153A1
(en)
|
2005-04-05 |
2006-10-05 |
Luca Technologies, Llc |
Generation of materials with enhanced hydrogen content from anaerobic microbial consortia
|
EP1877565A4
(en)
|
2005-05-03 |
2011-11-16 |
Anaerobe Systems |
Anaerobic production of hydrogen and other chemical products
|
JP2006314219A
(en)
*
|
2005-05-11 |
2006-11-24 |
Asahi Breweries Ltd |
Method for adsorbing bile acid utilizing enterobacterium, and bile acid-adsorbing substance
|
JP2007031291A
(en)
*
|
2005-07-22 |
2007-02-08 |
Ace Bio Product Kk |
Body weight increase-inhibiting agent and body weight increase-inhibiting drink
|
FR2889958A1
(en)
|
2005-08-25 |
2007-03-02 |
Lyoct Sa Lab |
USE OF A SYMBIOTIC FOR THE TREATMENT OF ATOPIC DERMATITIS
|
EP1776877A1
(en)
|
2005-10-21 |
2007-04-25 |
N.V. Nutricia |
Method for stimulating the intestinal flora
|
MX2008009726A
(en)
*
|
2006-01-27 |
2009-03-05 |
Danisco |
Use.
|
ITRM20060237A1
(en)
|
2006-05-03 |
2007-11-04 |
Anabasis S R L |
USE OF PROBIOTICS IN THE PREVENTION AND TREATMENT OF ALLERGIC CONJUNCTIVES
|
ATE526962T1
(en)
|
2006-05-18 |
2011-10-15 |
Biobalance Llc |
BIOTHERAPEUTIC COMPOSITION CONTAINING PROBIOTIC ESCHERICHIA COLI AND METRONIDAZOLE AND USES THEREOF
|
CN1850047A
(en)
|
2006-06-01 |
2006-10-25 |
济南帅华医药科技有限公司 |
Slow-release preparation containing beta-lactamase inhibitor and cephalosporin and its use
|
JP5019563B2
(en)
|
2006-06-16 |
2012-09-05 |
旭化成ケミカルズ株式会社 |
Intestinal bacteria activator
|
CN101095698B
(en)
|
2006-06-26 |
2010-12-01 |
青岛东海药业有限公司 |
Use of Clostridium Butyricum for preventing and treating foetid faeces toxin syndrome and disease
|
US7867578B2
(en)
*
|
2006-06-28 |
2011-01-11 |
Applied Materials, Inc. |
Method for depositing an amorphous carbon film with improved density and step coverage
|
US20080069861A1
(en)
|
2006-09-19 |
2008-03-20 |
National Starch And Chemical Investment Holding Corporation |
Probiotic/Non-Probiotic Combinations
|
WO2008076696A2
(en)
|
2006-12-18 |
2008-06-26 |
Washington University In St. Louis |
The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
US20110020283A1
(en)
|
2007-02-22 |
2011-01-27 |
Schrezenmeir Juergen |
Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans
|
US9644210B2
(en)
|
2007-02-22 |
2017-05-09 |
Jürgen Schrezenmeir |
Probiotic gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in human
|
KR20100016012A
(en)
|
2007-03-28 |
2010-02-12 |
앨러멘터리 헬스 리미티드 |
Probiotic bifidobacterium strains
|
AU2008231467A1
(en)
|
2007-03-28 |
2008-10-02 |
Alimentary Health Limited |
Probiotic Bifidobacterium strains
|
CA2684713C
(en)
|
2007-05-03 |
2019-02-19 |
Tobias Olofsson |
Lactobacillus or bifidobacterium isolated from honey or honey producing tracts of honey bees
|
TW200904340A
(en)
|
2007-05-11 |
2009-02-01 |
Mannatech Inc |
Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
|
EP1992351B1
(en)
|
2007-05-18 |
2016-05-11 |
Nestec S.A. |
Lactobacillus johnsonii for prevention of postsurgical infection
|
US20090010892A1
(en)
*
|
2007-07-06 |
2009-01-08 |
Toa Pharmaceutical Co., Ltd. |
Hyperlipidemia Treatment Agent
|
US20090010891A1
(en)
*
|
2007-07-06 |
2009-01-08 |
Toa Pharmaceutical Co., Ltd. |
Sepsis Treatment Agent
|
WO2009018447A2
(en)
|
2007-07-31 |
2009-02-05 |
New York University |
Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
|
EP2030623A1
(en)
|
2007-08-17 |
2009-03-04 |
Nestec S.A. |
Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
|
WO2009043856A2
(en)
|
2007-10-01 |
2009-04-09 |
University College Cork, National University Of Ireland, Cork |
Modulation of tissue fatty acid composition of a host by human gut bacteria
|
US8478544B2
(en)
|
2007-11-21 |
2013-07-02 |
Cosmosid Inc. |
Direct identification and measurement of relative populations of microorganisms with direct DNA sequencing and probabilistic methods
|
EP2072052A1
(en)
|
2007-12-17 |
2009-06-24 |
Nestec S.A. |
Prevention of opportunistic infections in immune-compromised subjects
|
ES2343499B1
(en)
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
MICROORGANISMS TO IMPROVE THE STATE OF HEALTH OF INDIVIDUALS WITH DISORDERS RELATED TO THE INTAKE OF GLUTEN.
|
EP2110028A1
(en)
|
2008-04-15 |
2009-10-21 |
Nestec S.A. |
Bifidobacterium longum and hippocampal BDNF expression
|
US20110189149A1
(en)
|
2008-06-20 |
2011-08-04 |
Remy Burcelin |
New Uses of Lactic Acid Bacteria and Bifidobacteria
|
WO2010003916A1
(en)
|
2008-07-11 |
2010-01-14 |
Chr. Hansen A/S |
New probiotic bifidobacterium longum
|
US8569466B2
(en)
|
2008-09-10 |
2013-10-29 |
Nnochiri Ekwuribe |
Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
|
US9603876B2
(en)
|
2008-09-25 |
2017-03-28 |
New York University |
Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
|
WO2010040055A2
(en)
|
2008-10-03 |
2010-04-08 |
Intekrin Therapeutics, Inc. |
Oral pharmaceutical formulations for antidiabetic compounds
|
CN102984955B
(en)
|
2008-11-11 |
2015-01-07 |
营养健康有限公司 |
Bifidobacterium longum
|
JP5606672B2
(en)
|
2008-11-26 |
2014-10-15 |
太陽化学株式会社 |
Intestinal environment adjustment method using symbiotics
|
WO2010096550A2
(en)
|
2009-02-18 |
2010-08-26 |
University Of Florida Research Foundation, Inc. |
Lactobacillus supplement for alleviating type 1 diabetes
|
KR20190000937A
(en)
*
|
2009-02-24 |
2019-01-03 |
리터 파마슈티컬즈 인코오포레이티드 |
Prebiotic formulations and methods of use
|
US20100086981A1
(en)
|
2009-06-29 |
2010-04-08 |
Qteros, Inc. |
Compositions and methods for improved saccharification of biomass
|
DK2411027T3
(en)
*
|
2009-03-25 |
2015-01-19 |
Chr Hansen As |
USING a probiotic ADJUSTING body weight
|
EP2411026A1
(en)
|
2009-03-25 |
2012-02-01 |
Chr. Hansen A/S |
Use of probiotics to ameliorate diet-induced insulin resistance
|
CA2761150C
(en)
|
2009-05-07 |
2017-06-13 |
Tate & Lyle Ingredients France SAS |
Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
|
US10576110B2
(en)
|
2009-05-11 |
2020-03-03 |
Societe Des Produits Nestle S.A. |
Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
|
CN102458415B
(en)
|
2009-06-19 |
2015-05-20 |
杜邦营养生物科学有限公司 |
Bifidobacteria for treating diabetes and related conditions
|
US20150320808A1
(en)
|
2009-06-19 |
2015-11-12 |
Dupont Nutrition Biosciences Aps |
Bifidobacteria for treating cardiac conditions
|
US9848760B2
(en)
|
2009-06-29 |
2017-12-26 |
Gearbox, Llc |
Devices for continual monitoring and introduction of gastrointestinal microbes
|
WO2011011094A1
(en)
|
2009-07-24 |
2011-01-27 |
Dowd Scot E |
Universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
|
CN102470152A
(en)
|
2009-07-30 |
2012-05-23 |
丹尼斯科公司 |
Lactic acid bacteria and bifidobacteria for treating endotoxemia
|
DK2289527T3
(en)
|
2009-08-25 |
2018-04-23 |
Nestec Sa |
BIFIDOBACTERIUM LONGUM AND FUNCTIONAL GI DISEASES
|
EP2486143A1
(en)
|
2009-10-05 |
2012-08-15 |
AAK Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
KR100962365B1
(en)
|
2009-10-07 |
2010-06-10 |
주식회사 대일 |
A container for transport of live-fish
|
EP2498626B1
(en)
|
2009-11-12 |
2015-06-17 |
Nestec S.A. |
Nutritional composition for promoting gut microbiota balance and health
|
WO2011073769A2
(en)
|
2009-12-16 |
2011-06-23 |
Probiotical S.P.A. |
Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
NL2004201C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides to modulate the immune system.
|
WO2011099514A1
(en)
|
2010-02-10 |
2011-08-18 |
日環科学株式会社 |
Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
|
JP2013520972A
(en)
|
2010-03-01 |
2013-06-10 |
アンスティテュ ナシオナル ドゥ ラ ルシェルシュ アグロノミック |
Diagnosis method of inflammatory bowel disease
|
US20130005586A1
(en)
|
2010-03-01 |
2013-01-03 |
Stanislav Ehrlich |
Method of diagnostic of obesity
|
IT1398553B1
(en)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
COMPOSITION INCLUDING PROBIOTIC BACTERIA FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH THE ALTERATION OF THE IMMUNE SYSTEM.
|
KR101690616B1
(en)
*
|
2010-04-12 |
2016-12-28 |
엘지전자 주식회사 |
A method and apparatus for efficient feedback in a wireless communication system supporting multiple antenna
|
WO2011137249A1
(en)
|
2010-04-28 |
2011-11-03 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
FI20105478A0
(en)
|
2010-04-30 |
2010-04-30 |
Valtion Teknillinen |
Procedure for Diagnosing Type 1 Diabetes and Procedures and Compositions for Preventing Type 1 Diabetes Outbreak
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
WO2011151941A1
(en)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
Composition having activity of inducing proliferation or accumulation of regulatory t cell
|
WO2012002322A1
(en)
|
2010-06-28 |
2012-01-05 |
株式会社ヤクルト本社 |
Skin properties improving agent for oral administration
|
US9192554B2
(en)
|
2010-06-30 |
2015-11-24 |
Nestec S.A. |
Use of chicoric acid and lactic bacterium in food supplement for regulating skin pigmentation
|
US20130143288A1
(en)
*
|
2010-08-12 |
2013-06-06 |
The Administrators Of The Tulane Educational Fund |
Isolated bacteria, methods for use, and methods for isolation
|
US9386793B2
(en)
|
2010-08-20 |
2016-07-12 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
CA2811056A1
(en)
|
2010-09-10 |
2012-03-15 |
Viropharma Incorporated |
Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
|
EP2944690B1
(en)
|
2010-10-11 |
2017-12-20 |
Jennewein Biotechnologie GmbH |
Novel fucosyltransferases and their applications
|
US20120165792A1
(en)
|
2010-12-22 |
2012-06-28 |
Ethicon Endo-Surgery, Inc. |
Pill Catchers
|
EP2658559A1
(en)
*
|
2010-12-29 |
2013-11-06 |
Nestec S.A. |
Fiber and probiotics for reducing intestinal symptoms related to stress
|
US10245288B2
(en)
|
2011-02-04 |
2019-04-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
|
CN111518866A
(en)
|
2011-03-01 |
2020-08-11 |
群体创新有限责任公司 |
Materials and methods for treating conditions associated with pathogenic biofilms
|
EP4129312A1
(en)
|
2011-03-09 |
2023-02-08 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
CN102254089A
(en)
|
2011-04-18 |
2011-11-23 |
王钰 |
System simulating method and system
|
ITMI20110793A1
(en)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD.
|
EP2797606A4
(en)
|
2011-08-17 |
2015-09-30 |
MicroBiome Therapeutics LLC |
Composition and use of a formulation to increase the ratio of gastrointestinal microbiota in phylum bacteriodites to microbiota of firmuctes phylum
|
US9493737B2
(en)
|
2011-08-18 |
2016-11-15 |
Chr. Hansen A/S |
Method for purifying bacterial cells
|
SG11201401811WA
(en)
|
2011-08-30 |
2014-09-26 |
Amc Amsterdam |
Method for preventing and/or treating insulin resistance
|
ES2662793T3
(en)
|
2011-09-14 |
2018-04-09 |
Nubiyota Llc |
Media supplements and methods for growing human gastrointestinal anaerobic microorganisms
|
US20130121968A1
(en)
|
2011-10-03 |
2013-05-16 |
Atossa Genetics, Inc. |
Methods of combining metagenome and the metatranscriptome in multiplex profiles
|
GB201117313D0
(en)
*
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
FI20116008A0
(en)
|
2011-10-12 |
2011-10-12 |
Maeyrae Maekinen Annika |
Prevention and diagnosis of visceral fat
|
US9649346B2
(en)
|
2011-11-02 |
2017-05-16 |
Bios Llc |
Probiotic stick formulation for skin maintenance and methods of use
|
KR20140093252A
(en)
|
2011-11-04 |
2014-07-25 |
제네랄밀즈인코포레이팃드 |
Methods and compositions for modulating gastrointestinal bacteria to promote health
|
EP3978598A1
(en)
|
2011-12-01 |
2022-04-06 |
The University of Tokyo |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
MY172363A
(en)
|
2011-12-07 |
2019-11-21 |
Asahi Group Holdings Ltd |
Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
|
ES2659947T3
(en)
|
2012-01-19 |
2018-03-20 |
University College Cork-National University Of Ireland, Cork |
Cultivable GABA producing bacteria derived from the human gastrointestinal tract
|
US9173910B2
(en)
|
2012-02-29 |
2015-11-03 |
The General Hospital Corporation |
Compositions of microbiota and methods related thereto
|
ES2436251B1
(en)
|
2012-05-25 |
2014-10-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
BACTEROIDS CECT 7771 AND ITS USE IN THE PREVENTION AND TREATMENT OF OVERWEIGHT, OBESITY AND METABOLIC AND IMMUNOLOGICAL ALTERATIONS.
|
US20130344042A1
(en)
|
2012-06-20 |
2013-12-26 |
Gretchen Tanbonliong |
Dietary management of celiac disease and food allergy
|
WO2014011233A1
(en)
*
|
2012-07-09 |
2014-01-16 |
Trachtman Ira Milton |
Compositions and method for treatment and prophylaxis of inflammatory bowel disease
|
EP2885396B1
(en)
|
2012-08-20 |
2020-02-19 |
Chr. Hansen A/S |
Method for optimizing a process for freeze drying a bacteria-containing concentrate
|
CA3092314A1
(en)
*
|
2012-09-20 |
2014-03-27 |
Prothera, Inc. |
Probiotic compositions and methods for the treatment of obesity and obesity-related conditions
|
AU2013338774B2
(en)
|
2012-11-01 |
2017-03-02 |
Academisch Ziekenhuis Groningen |
Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
|
WO2014075745A1
(en)
*
|
2012-11-19 |
2014-05-22 |
Université Catholique de Louvain |
Use of akkermansia for treating metabolic disorders
|
EP2919796B1
(en)
|
2012-11-19 |
2021-04-28 |
Université catholique de Louvain |
Use of akkermansia for treating metabolic disorders
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
DK3628161T3
(en)
|
2012-11-23 |
2023-05-30 |
Seres Therapeutics Inc |
Synergistic bacterial compositions and methods of making and using the same
|
WO2014088982A1
(en)
|
2012-12-07 |
2014-06-12 |
Albert Einstein College Of Medicine Of Yeshiva University |
Gut barrier dysfunction treatment and prevention
|
WO2014121304A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions and methods
|
WO2014121301A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions and methods for inhibition of pathogenic bacterial growth
|
AU2014226633A1
(en)
|
2013-03-05 |
2015-09-03 |
Academisch Ziekenhuis Groningen |
Use of Faecali bacterium prausnitzii HTF-F (DSM 26943) to suppress inflammation.
|
CN110075130A
(en)
*
|
2013-03-14 |
2019-08-02 |
塞拉拜姆有限责任公司 |
The delivering of the targeting gastrointestinal tract of probiotics and/or therapeutic agent
|
US20160040215A1
(en)
|
2013-03-14 |
2016-02-11 |
Seres Therapeutics, Inc. |
Methods for Pathogen Detection and Enrichment from Materials and Compositions
|
US10716802B2
(en)
|
2013-03-15 |
2020-07-21 |
The Brigham And Women's Hospital, Inc. |
Compounds to modulate intestinal absorption of nutrients
|
AU2014232370B2
(en)
|
2013-03-15 |
2018-11-01 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
WO2014190251A1
(en)
|
2013-05-24 |
2014-11-27 |
Genomatica, Inc. |
Microorganisms and methods for producing (3r)-hydroxybutyl (3r)-hydroxybutyrate
|
US20160120915A1
(en)
|
2013-06-10 |
2016-05-05 |
New York University |
Methods for manipulating immune responses by altering microbiota
|
KR101470513B1
(en)
|
2013-07-17 |
2014-12-08 |
주식회사 아모그린텍 |
Soft Magnetic Cores Having Excellent DC Biased Characteristics in High Current and Core Loss Characteristics, and Manufacturing Methods thereof
|
US10633714B2
(en)
|
2013-07-21 |
2020-04-28 |
Pendulum Therapeutics, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
CA2926466C
(en)
|
2013-10-03 |
2021-11-16 |
Frederic Bushman |
Compositions comprising a defined microbiome and methods of use thereof
|
US10058576B2
(en)
|
2013-10-03 |
2018-08-28 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods comprising a defined microbiome and methods of use thereof
|
EP3060656A1
(en)
|
2013-10-24 |
2016-08-31 |
Yeda Research and Development Co., Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using same
|
GB201319531D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition & methods of screening
|
GB201319525D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition
|
GB201319539D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition & methods of screening
|
GB201319538D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition
|
GB201319540D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition
|
WO2015077794A1
(en)
|
2013-11-25 |
2015-05-28 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
KR20150066772A
(en)
|
2013-12-09 |
2015-06-17 |
주식회사 쎌바이오텍 |
A novel lactic acid bacteria and composition for preventing or treating diarrhea of an infant comprising the same
|
EP3082431A4
(en)
|
2013-12-16 |
2017-11-15 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
JP6527522B2
(en)
|
2013-12-20 |
2019-06-05 |
ネステク ソシエテ アノニム |
Nutritional composition for reducing enteric pathogens
|
WO2015089674A1
(en)
|
2013-12-20 |
2015-06-25 |
9286-3620 Québec Inc. |
Protein-based enteric coating for oral dosage forms
|
EP3102670A4
(en)
|
2014-02-04 |
2017-07-12 |
Micro-nature LLC |
Systems, methods, and compositions relating to combiomics
|
US20160354509A1
(en)
|
2014-02-10 |
2016-12-08 |
The Johns Hopkins University |
Devices for and methods of treatment of metabolic syndromes
|
US20160354418A1
(en)
|
2014-02-14 |
2016-12-08 |
Vesale Pharma Sa |
Use of compositions comprising bifidobacterium animalis ssp. lactis lmg p-28149
|
US20160367661A1
(en)
|
2014-02-27 |
2016-12-22 |
Yale University |
NLRP6 Inflammasome Intestinal Epithelium Mucus Secretion
|
US20150246081A1
(en)
|
2014-03-03 |
2015-09-03 |
Shayne Kenneth Morris |
Probiotics with methods for growth and use separately and in combination
|
US20150374760A1
(en)
|
2014-04-09 |
2015-12-31 |
Jose U. Scher |
Methods for treating psoriasis and psoriatic arthritis
|
CN111768837A
(en)
|
2014-04-28 |
2020-10-13 |
耶达研究及发展有限公司 |
Method and apparatus for predicting reaction to food
|
CN106460048B
(en)
|
2014-04-28 |
2021-01-05 |
耶达研究及发展有限公司 |
Microbiome response to agents
|
FI127483B
(en)
|
2014-06-11 |
2018-07-13 |
Gut Guide Oy |
Microbiomarker for celiac disease and a related product
|
MX2014009044A
(en)
|
2014-07-25 |
2016-01-25 |
Polioles S A De C V |
Novel molecules derived from phosphorylated 2-phenyl-imidazolines , having high imidazoline ring stability and a high level of effectiveness as corrosion inhibitors.
|
MX2017002155A
(en)
|
2014-08-18 |
2017-05-01 |
Nestec Sa |
Prebiotics for reducing the risk of obesity later in life.
|
US10410749B2
(en)
|
2014-10-21 |
2019-09-10 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
|
US9710606B2
(en)
|
2014-10-21 |
2017-07-18 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
|
US9760676B2
(en)
|
2014-10-21 |
2017-09-12 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions
|
CN107249611A
(en)
|
2014-10-24 |
2017-10-13 |
进化生物系统股份有限公司 |
The Bifidobacterium of activation and its application process
|
WO2016065419A1
(en)
|
2014-10-28 |
2016-05-06 |
Medlab Ip Pty Ltd |
Treatment for depression and depressive disorders
|
GB2551642B
(en)
*
|
2014-10-31 |
2020-09-23 |
Pendulum Therapeutics Inc |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
US20190102512A1
(en)
|
2014-11-17 |
2019-04-04 |
Yeda Research And Development Co., Ltd. |
Method of analyzing microbiome
|
MA41020A
(en)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND THEIR METHODS OF USE FOR MODULATION OF THE MICROBIOME
|
CN109496234A
(en)
|
2014-11-26 |
2019-03-19 |
波比奥泰克股份公司 |
For maintaining the lactobacillus of stable state and the bacterial strain of Bifidobacterium
|
US9688967B2
(en)
|
2014-12-05 |
2017-06-27 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
US20160206666A1
(en)
|
2014-12-22 |
2016-07-21 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
|
EP3242957B1
(en)
|
2015-01-09 |
2020-03-11 |
Wageningen Universiteit |
Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
|
KR20170128247A
(en)
|
2015-01-23 |
2017-11-22 |
템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
Use of short-chain fatty acids in cancer prevention
|
WO2016139217A1
(en)
|
2015-03-04 |
2016-09-09 |
Ab-Biotics, S.A. |
Composition comprising anaerobically cultivated human intestinal microbiota
|
MX2017011669A
(en)
|
2015-03-13 |
2017-11-06 |
Evolve Biosystems Inc |
Compositions that metabolize or sequester free sugar monomers and uses thereof.
|
US20160271189A1
(en)
|
2015-03-18 |
2016-09-22 |
Whole Biome, Inc. |
Methods and compositions relating to microbial treatment and diagnosis of skin disorders
|
WO2016176380A1
(en)
|
2015-04-28 |
2016-11-03 |
The Procter & Gamble Company |
Compositions comprising whole, non-viable micrococcus for improving skin health
|
EP3289093A4
(en)
|
2015-04-28 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
Use of microbial metabolites for treating diseases
|
WO2016177797A1
(en)
|
2015-05-06 |
2016-11-10 |
Wageningen Universiteit |
Use of a polypeptide for effecting immune signalling and/or affecting intestinal barrier function and/or modulating metabolic status
|
AU2016258976B2
(en)
|
2015-05-06 |
2021-02-25 |
Wageningen Universiteit |
Method of culturing Akkermansia
|
KR101589466B1
(en)
|
2015-05-21 |
2016-02-01 |
주식회사 쎌바이오텍 |
Use of bifidobacterium longum cbt bg7 strain for promoting growth and nutraceutical composition for promoting growth comprising the same
|
KR101589464B1
(en)
|
2015-05-21 |
2016-02-01 |
주식회사 쎌바이오텍 |
New bifidobacterium strain and nutraceutical composition for improving growth comprising the same
|
EP3297727A1
(en)
|
2015-05-21 |
2018-03-28 |
Yeda Research and Development Co. Ltd |
Bacterial populations for promoting health
|
US20180140645A1
(en)
|
2015-05-30 |
2018-05-24 |
Japan Eco-Science Co., Ltd. |
Probiotic or prebiotic, method for producing same, microbial preparation, health food, and medicine
|
EP3915552A1
(en)
|
2015-06-01 |
2021-12-01 |
Xeno Biosciences Inc. |
Compositions for use in modulating the gut microbiota and managing weight
|
US20160355847A1
(en)
|
2015-06-03 |
2016-12-08 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Novel Clostridium Species That Converts Wheat Straw and Switchgrass Hydrolysates Into Butyric Acid
|
EP3307906B1
(en)
|
2015-06-09 |
2020-10-14 |
Regents of the University of Minnesota |
Methods for detecting risk of having a bloodstream infection
|
GB201514303D0
(en)
|
2015-07-16 |
2015-09-23 |
Dupont Nutrition Biosci Aps |
Bifidobacteria for treating cardiac conditions
|
EP3328215B1
(en)
|
2015-07-29 |
2021-07-07 |
Advanced BioNutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
EP3331499A4
(en)
|
2015-08-06 |
2019-04-10 |
The Johns Hopkins University |
Composition and method for treatment of metabolic disorders
|
US10300043B2
(en)
|
2015-08-12 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof
|
CN105030841A
(en)
|
2015-08-24 |
2015-11-11 |
上海交通大学医学院附属瑞金医院 |
Application of Akkermansia muciniphila BAA-835 strain
|
JP7088827B2
(en)
|
2015-08-24 |
2022-06-21 |
ニューバイヨタ エルエルシー |
Treatment system and method for dysbiosis using fecal-derived bacterial population
|
CN105106245A
(en)
|
2015-08-24 |
2015-12-02 |
上海交通大学医学院附属瑞金医院 |
Application of Akkermansia muciniphila BAA-835 bacterial strain
|
WO2017035412A1
(en)
|
2015-08-25 |
2017-03-02 |
Kaleido Biosciences, Inc. |
Glycan compositions and uses thereof
|
EP3341082B1
(en)
|
2015-08-27 |
2020-12-16 |
PrecisionBiotics Group Limited |
Bifidobacterium longum
|
EP3341081B1
(en)
|
2015-08-27 |
2020-11-11 |
PrecisionBiotics Group Limited |
Use of bifidobacterium longum and an exopolysaccharide produced thereby
|
WO2017041039A1
(en)
|
2015-09-04 |
2017-03-09 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for detecting risk of cancer relapse
|
PT3626081T
(en)
|
2015-09-10 |
2022-02-25 |
Univ Catholique Louvain |
Pasteurized akkermansia for promoting weight loss
|
WO2017047968A1
(en)
|
2015-09-15 |
2017-03-23 |
경희대학교 산학협력단 |
Novel lactobacillus having various functions, and use thereof
|
JP2018534277A
(en)
|
2015-10-05 |
2018-11-22 |
シュヴァイツェリッシェ フォルシュングスインスティテュート フュア ホーフゲブリクスクリーマ ウント メディツィン イン ダヴォス |
Use of Akkermansia muciniphila for treating inflammatory conditions
|
WO2017060468A1
(en)
|
2015-10-07 |
2017-04-13 |
Galderma Research & Development |
Composition containing lactic acid bacteria and its use to treat atopic dermatitis
|
BR112018007560A2
(en)
|
2015-10-15 |
2018-10-23 |
Natura Cosméticos S.A. |
cosmetic composition having probiotic bacteria
|
EP3368050A1
(en)
|
2015-10-26 |
2018-09-05 |
Crestovo Holdings LLC |
Compositions and methods for fecal microbiota-related therapy
|
IL298281A
(en)
|
2015-11-03 |
2023-01-01 |
Brigham & Womens Hospital Inc |
Therapeutic microbiota for the treatment and/or prevention of food allergy
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
AU2016359178A1
(en)
|
2015-11-24 |
2018-06-14 |
Seres Therapeutics, Inc. |
Designed bacterial compositions
|
US9668991B1
(en)
|
2015-12-09 |
2017-06-06 |
International Business Machines Corporation |
SCFA colonic composition
|
BR112018011665A2
(en)
|
2015-12-11 |
2018-12-04 |
Alimentary Health Ltd |
bifidobacterium longum for the treatment of obesity and associated metabolic disorders
|
US10548844B2
(en)
|
2015-12-14 |
2020-02-04 |
Massachusetts Institute Of Technology |
pH-responsive mucoadhesive polymeric encapsulated microorganisms
|
RU2743405C2
(en)
|
2015-12-14 |
2021-02-18 |
Метабоген Аб |
Treatment of intrahepatic cholestasis and related liver diseases
|
JPWO2017130859A1
(en)
|
2016-01-28 |
2018-11-15 |
森永乳業株式会社 |
Nerve cell death inhibitor
|
PL3411052T3
(en)
|
2016-02-04 |
2021-03-08 |
Universiteit Gent |
Use of microbial communities for human and animal health
|
WO2017146580A1
(en)
|
2016-02-25 |
2017-08-31 |
Caelus Pharmaceuticals B.V. |
Compositions and methods for preventing and/or treating vitamin b12 deficiency
|
EP3431089A4
(en)
|
2016-03-14 |
2020-04-15 |
B Food Science Co., Ltd. |
Agent for increasing intestinal butyric acid and proliferation agent for butyric acid-producing bacteria
|
EP3551201A4
(en)
|
2016-12-06 |
2020-06-24 |
Pendulum Therapeutics, Inc. |
Methods and compositions relating to isolated and purified microbes
|
US20180357375A1
(en)
|
2017-04-04 |
2018-12-13 |
Whole Biome Inc. |
Methods and compositions for determining metabolic maps
|
CN111212655A
(en)
|
2017-08-14 |
2020-05-29 |
赛里斯治疗公司 |
Compositions and methods for treating cholestatic diseases
|
JP2020532515A
(en)
|
2017-08-30 |
2020-11-12 |
ペンデュラム セラピューティクス, インコーポレイテッド |
Methods and compositions for the treatment of microbiome-related disorders
|
AU2019349678A1
(en)
|
2018-09-24 |
2021-04-15 |
Pendulum Therapeutics, Inc. |
Microbial compositions and methods of use
|
JP2022533672A
(en)
|
2019-05-21 |
2022-07-25 |
ペンデュラム セラピューティクス, インコーポレイテッド |
Methods and compositions for treating liver damage
|
US20230050043A1
(en)
|
2019-12-23 |
2023-02-16 |
Pendulum Therapeutics, Inc. |
Compositions Comprising Microbes and Methods of Use and Making Thereof
|